Batlle Juan F

Armstrong James J, De Francesco Ticiana, Beckers Henny J, Stalmans Ingeborg, Fea Antonio M, Sng Chelvin C A et al.

This study compared three primary glaucoma surgeries, finding SIBS microshunt achieved higher success and fewer complications than gelatin microstent or trabeculectomy, suggesting it's a superior option.

Batlle Juan F, Corona Adalgisa, Albuquerque Rachel

The PRESERFLO MicroShunt for POAG showed sustained IOP and medication reduction for 5 years. This suggests it's a safe, effective long-term treatment option with no sight-threatening adverse events.

Batlle Juan F, Fantes Francisco, Riss Isabelle, Pinchuk Leonard, Alburquerque Rachel, Kato Yasushi P et al.

This 3-year study found the InnFocus MicroShunt effectively lowered IOP to the low teens with minimal medications and transient side effects, offering a safe, sustained glaucoma treatment option.